← SynDRA
FINGOLIMOD
SynDRA canonical compound SYN0003587 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | S1PR4 |
|---|
| Mechanism of action | Sphingosine 1 phosphate receptor agonist |
|---|
| Indication | multiple sclerosis |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- S1PR1
- S1PR5
- S1PR3
- S1PR4
- SPHK1
- CYP2E1
- CYP4F2
- DRD3
- S1PR2
- SGPL1
- Sgpl1
- Trpm7
Mechanisms of action (all sources)
- Immunosuppressant
- Sphingosine 1 phosphate receptor agonist
- S1PR5 AGONIST
- Sphingosine 1-phosphate receptor agonist
- S1PR2 AGONIST
- S1PR4 AGONIST
- S1PR3 AGONIST
- S1PR1 AGONIST
- S1PR5 BINDING AGENT
- Sphingosine 1-phosphate receptor binding agent
- S1PR2 BINDING AGENT
- S1PR4 BINDING AGENT
Drug classes
- Immunologic Factors
- Immunosuppressive Agents
- Sphingosine 1 Phosphate Receptor Modulators
- Sphingosine 1-Phosphate Receptor Modulators
- Sphingosine 1-phosphate Receptor Modulator
ATC classes
- L04A · IMMUNOSUPPRESSANTS
Cross-references
Synonyms
- FTY-720
- fingolimod hydrochloride
- gilenya
- fingolimod HCl
- 2-Amino-2-(4-octylphenethyl)propane-1,3-diol
- GSK618334
- Fingolimod hydrochloride
- FTY720
- Fingolimod HCl
- Gilenya
- Gilenia
- Fty 720
- Fingolimod (FTY720) HCl
- Fingolimod (hydrochloride)
- 2-Amino-2-(4-octylphenethyl)propane-1,3-diol hydrochloride
- 2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride
- UNII-G926EC510T
- Fingolimod hydrochloride [USAN]
- CHEBI:63112
- G926EC510T
- 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride
- AK-33554
- 2-AMINO-2-[2-(4-OCTYL-PHENYL)-ETHYL]-PROPANE-1,3-DIOL HCL
- Fingolimod-d4 Hydrochloride
- Fty-720
- 1,3-Propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-
- 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol
- 3QN8BYN5QF
- 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
- 1,3-Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-
- fingolimodum
- CHEBI:63115
- RefChem:57690
- DTXCID0089854
- L04AA27
- 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol
- Fingolimod [INN]
- 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol
Reported adverse events
- Bradycardia
- Cough
- Headache
- Hypersensitivity
- Hypertension
- Infection
- Nausea
- Bradyarrhythmia
- Alopecia
- Lymphopenia
- Seizure
- T-cell lymphoma
Look up FINGOLIMOD in the interactive SynDRA portal →